Solid Biosciences Inc. Employee Count
The employee counts Solid Biosciences Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 121; Filing 2026-03-19; Lease expense per employee $29,983.47.
- 2024-12-31: Employees (as filed) 100; Filing 2025-03-06; Lease expense per employee $43,380.00.
- 2021-12-31: Employees (as filed) 104; Filing 2022-03-14; Lease expense per employee $24,692.31.
- 2019-12-31: Employees (as filed) 121; Filing 2020-03-12; Lease expense per employee $20,661.16.
- Available history
- 2018-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 121 full-time | 2026-03-19 | $29,983.47 total lease cost |
| 2024-12-31 | 100 full-time | 2025-03-06 | $43,380.00 total lease cost |
| 2021-12-31 | 104 full-time | 2022-03-14 | $24,692.31 total lease cost |
| 2019-12-31 | 121 full-time | 2020-03-12 | $20,661.16 total lease cost |
| 2018-12-31 | 111 full-time | 2019-03-13 | $22,738.74 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |